“As you can imagine, the pain we suffered with Gary and 657 of my other friends and colleagues at Cantor Fitzgerald were killed on 9/11,” Lutnick said during his confirmation hearing before ...

Lutnick is currently CEO of Cantor Fitzgerald, a financial services firm ... and immigration into the U.S. Sen. Gary Peters, D-Mich., raised concerns about the impact of those tariffs on the ...

Meanwhile, his firm, Cantor Fitzgerald has a significant presence in Ireland, with offices in Cork, Dublin and Limerick Howard Lutnick, chairman and chief executive officer of Cantor Fitzgerald ...

Prenetics Global Limited (NASDAQ:PRE – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2025 earnings estimates for shares of Prenetics Global in a research note issued ...

In a report released yesterday, C J Muse from Cantor Fitzgerald maintained a Hold rating on KLA (KLAC – Research Report), with a price target of $875.00. The company’s shares closed yesterday ...

On Friday, Cantor Fitzgerald reaffirmed its Overweight rating on Cipher Mining shares (NASDAQ:CIFR), with a set price target of $11.00. The firm's analyst, Brett Knoblauch, provided insight into ...

Cantor is the widow of Bernie Cantor, who founded financial firm Cantor Fitzgerald, whose current CEO, Robert Lutnick, is President Donald Trump’s pick for commerce secretary. Cantor could not ...

Cantor Fitzgerald has a “Overweight” rating and a $11.50 price objective on the stock. The consensus estimate for Ranpak’s current full-year earnings is ($0.20) per share. Get Ranpak alerts: ...

This month, Flagstar offloaded $142 million of that portfolio, finding a buyer in Howard Lutnick’s Cantor Fitzgerald, PincusCo reported. A spokesperson for Cantor Fitzgerald did not return a ...

On Wednesday, Cantor Fitzgerald initiated coverage on Galaxy Digital Holdings Ltd (TSX:GLXY:CN) (OTC: BRPHF), assigning an Overweight rating to the company's stock with a price target of Cdn$44.00.

Cantor Fitzgerald assumed coverage of Cidara Therapeutics (CDTX) with an Overweight rating. Cidara’s lead asset CD388, an anti-viral that targets neuraminidase, an essential surface receptor ...